Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Feb 26, 2021 · 10-K · 57 days after period end · 0001280776-21-000009
| Metric | Q4 2020 | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$11.16M | -$7.69M | -$4.81M | -$14.59M |
| EPS Diluted | -$0.53 | -$0.75 | -$5.68 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 26, 2021 · 57 d after period end
